The HER2 target for designing novel multi-peptide vaccine against breast cancer using immunoinformatics and molecular dynamic simulation.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- The HER2 target for designing novel multi-peptide vaccine against breast cancer using immunoinformatics and molecular dynamic simulation.
- Published In:
- Biochemistry and biophysics reports, 43, 102135 (2025)
- Authors:
- Firuzpour, Faezeh, Barancheshmeh, Maryam, Ziarani, Fariba Fallah, Karami, Leila, Aram, Cena
- Database ID:
- RPEP-10958
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-10958APA
Firuzpour, Faezeh; Barancheshmeh, Maryam; Ziarani, Fariba Fallah; Karami, Leila; Aram, Cena. (2025). The HER2 target for designing novel multi-peptide vaccine against breast cancer using immunoinformatics and molecular dynamic simulation.. Biochemistry and biophysics reports, 43, 102135. https://doi.org/10.1016/j.bbrep.2025.102135
MLA
Firuzpour, Faezeh, et al. "The HER2 target for designing novel multi-peptide vaccine against breast cancer using immunoinformatics and molecular dynamic simulation.." Biochemistry and biophysics reports, 2025. https://doi.org/10.1016/j.bbrep.2025.102135
RethinkPeptides
RethinkPeptides Research Database. "The HER2 target for designing novel multi-peptide vaccine ag..." RPEP-10958. Retrieved from https://rethinkpeptides.com/research/firuzpour-2025-the-her2-target-for
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.